Antipsychotic Properties of Des-Enkephalin-γ-Endorphin in Treatment of Schizophrenic Patients
- 1 June 1982
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 39 (6) , 648-654
- https://doi.org/10.1001/archpsyc.1982.04290060010003
Abstract
From JAMA Psychiatry — Antipsychotic Properties of Des-Enkephalin-γ-Endorphin in Treatment of Schizophrenic PatientsThis publication has 17 references indexed in Scilit:
- (Des-Tyr1)-γ-endorphin in the treatment of schizophreniaPsychological Medicine, 1981
- Use of Naloxone in Schizophrenic Psychoses and Manic SyndromesNeuropsychobiology, 1981
- Neuroleptic-like activity of peptides related to [DES-TYR1] γ-endorphin: Structure activity studiesLife Sciences, 1980
- Effects of the Synthetic Analogue of Methionine Enkephalin FK 33-824 on Psychotic SymptomsPharmacopsychiatry, 1979
- SYNTHETIC ENKEPHALIN ANALOGUE IN TREATMENT OF SCHIZOPHRENIAThe Lancet, 1979
- EEG and Clinical Profile of a Synthetic Analogue of Methionine-Enkephalin – FK 33–824Pharmacopsychiatry, 1979
- Research Diagnostic CriteriaArchives of General Psychiatry, 1978
- Naloxone-induced reversal of schizophrenic hallucinationsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1977
- Endorphins, Brain Peptides That Act like OpiatesNew England Journal of Medicine, 1977
- Clozapine versus Perphenazine: The Value of the Biochemical Mode of Action of Neuroleptics in Predicting their Therapeutic ActivityThe British Journal of Psychiatry, 1976